MedPath
FDA Product

OLANZAPINE

Product approved by U.S. Food and Drug Administration (US)

Basic Information

OLANZAPINE

13668-089

Regulatory Information

13668-089

ANDA091415

C73584

December 8, 2022

USA

These highlights do not include all the information needed to use OLANZAPINE safely and effectively. See full prescribing information for OLANZAPINE. OLANZAPINE tablets, for oral use OLANZAPINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1996

HUMAN PRESCRIPTION DRUG LABEL

15

Company Information

650175722

Active Ingredients

ASPARTAME

Code: Z0H242BBR1

Class Code: IACT

CELLULOSE, MICROCRYSTALLINE

Code: OP1R32D61U

Class Code: IACT

CROSPOVIDONE

Code: 2S7830E561

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

OLANZAPINE

Quantity: 15 mg in 1 1

Code: N7U69T4SZR

Class Code: ACTIB

MANNITOL

Code: 3OWL53L36A

Class Code: IACT

Active Moieties

OLANZAPINE

Code: N7U69T4SZR

© Copyright 2025. All Rights Reserved by MedPath